Welcome to our dedicated page for Clever Leaves Holdings news (Ticker: CLVR), a resource for investors and traders seeking the latest updates and insights on Clever Leaves Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clever Leaves Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clever Leaves Holdings's position in the market.
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) will host a conference call on August 12, 2021, at 5:00 p.m. ET to discuss its Q2 2021 results. The company will issue a press release with its financial results before the call. Interested parties can join via toll-free or international dial-in numbers, with a conference ID of 21996432. A live broadcast and replay will be available post-call. Clever Leaves is recognized for its sustainable cannabis operations across multiple countries with various international certifications.
Clever Leaves has partnered with Biopharmaceutical Research Company and UC Davis to study the DNA of its cannabis cultivars as part of Project Change Lives. This initiative aims to contribute $25 million in cannabis products for research into cannabinoid medicine. UC Davis will lead the genetic analysis, providing foundational data for future cannabis breeding and pharmaceutical development. Clever Leaves will supply up to 250,000 bottles of cannabis oil and 5 tons of flower for research, ensuring that the materials are provided at no cost to participants, enhancing access to critical cannabis research.
Clever Leaves Holdings has received authorization to export dry cannabis flower from Colombia, significantly expanding its market reach. Signed by President Ivan Duque on July 23, 2021, this decree allows Clever Leaves to tap into a market representing 50% of global medical cannabis sales. The company boasts a 1.8 million square foot cultivation area certified for quality production. This regulatory change aims to enhance the Colombian cannabis industry and streamline export processes. Clever Leaves plans to leverage its global partnerships to deliver innovative products for medical use worldwide.
Clever Leaves Holdings Inc. (NASDAQ: CLVR) has launched Project Change Lives, a U.S.-focused initiative aimed at advancing cannabis research. The company will contribute up to USD $25 million in pharmaceutical-grade cannabis products to eligible organizations at no cost, providing up to 250,000 bottles of cannabis oil and 5 tons of cannabis flower. This collaboration with the Biopharmaceutical Research Company addresses research delays and aims to enhance patient access to medical cannabis. The project also invites proposals from accredited researchers seeking medical cannabis for studies.
Clever Leaves Holdings (NASDAQ: CLVR) has announced a significant partnership with CBD Life Holding, an emerging leader in the Mexican cannabis industry. This agreement marks Clever Leaves' first commercial venture in Mexico, where it will supply active pharmaceutical ingredients (APIs) including CBD isolate for CBD Life's medical cannabis products. The Mexican medical cannabis market is projected to reach $60 million by 2024. The partnership is expected to leverage Clever Leaves' expertise in pharmaceutical-grade cannabis and CBD Life's extensive distribution network of over 18,000 retail points.
Clever Leaves Holdings Inc. (NASDAQ: CLVR) has partnered with Verdemed Holdings Inc. to supply EU-GMP and INVIMA certified CBD products in Brazil and Peru. The collaboration aims to enhance access to cannabinoid-based pharmaceuticals in these growing markets. The partnership will provide finished CBD oral solutions, catering to various medical needs. Brazil's medical cannabis user base is projected to near 3 million, while Peru's market could reach $100 million. This strategic alliance positions Clever Leaves to capitalize on the expanding demand for quality cannabis products in Latin America.
Clever Leaves has partnered with Ethypharm, a European pharmaceutical firm, to market EU-GMP certified medical cannabis products in Germany. The deal involves high-CBD and high-THC formulations aimed at treating Central Nervous System diseases and chronic pain. Clever Leaves’ CEO, Kyle Detwiler, emphasizes this partnership as a significant step into the German market, which is critical for growth in Europe. Clever Leaves holds multiple international certifications, enhancing its operational capabilities for global distribution.
On January 11, 2021, Virtual Investor Conferences and KCSA Strategic Communications announced that presentations from the January 7 Cannabis Industry Virtual Investor Conference are now available for on-demand viewing at VirtualInvestorConferences.com. The presentations will be accessible for 90 days, and participants can download shareholder materials from the virtual trade booth for three weeks. Companies that presented include Clever Leaves International (NASDAQ: CLVR) among others. This event aims to enhance investor engagement and provide a platform for publicly-traded companies.
The Cannabis Industry Virtual Investor Conference is set for January 7, 2021, starting at 10:00 AM ET. The event invites individual and institutional investors to hear from a variety of cannabis companies, including Clever Leaves International (NASDAQ: CLVR). Attendees are encouraged to pre-register and participate in live presentations without fees. The conference aims to enhance investor awareness, featuring a robust lineup of companies presenting their agendas for the year. This marks the 12th virtual cannabis conference since 2017, reflecting ongoing interest in the sector.